Canine CA-724 antibody and antigen (recombinant protein)

Diagnostic anti-Canine CA-724 antibodies pairs and antigen for animal health (animal Dog/Canine carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-CAN-CA-724-Ag01 Recombinant Canine CA-724 protein 3090
GMP-CAN-CA-724-Ab01 Anti-Canine CA-724 mouse monoclonal antibody (mAb) 1953
GMP-CAN-CA-724-Ab02 Anti-Canine CA-724 mouse monoclonal antibody (mAb) 1953
GMP-CAN-CA-724-Ab03 Anti-Canine CA-724 human monoclonal antibody (mAb) 1953
GMP-CAN-CA-724-Ab04 Anti-Canine CA-724 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-CAN-CA-724-Ag01
Product Name Recombinant Canine CA-724 protein
Target/Biomarker Canine Cancer Antigen 72-4 (AIV-A N8 subtype)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Canine Cancer Antigen 72-4 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AIV-A N8 subtype level test of animal Dog/Canine with carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium.
Tag His
Products description Recombinant Canine CA-724 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-CAN-CA-724-Ab01, GMP-CAN-CA-724-Ab02
Product Name Anti-Canine CA-724 mouse monoclonal antibody (mAb)
Target/Biomarker Canine Cancer Antigen 72-4 (AIV-A N8 subtype)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Canine Cancer Antigen 72-4 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N8 subtype antibodies in AIV-A N8 subtype level test of animal Dog/Canine with carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium.
Tag mFc
Products description Anti-Canine CA-724 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N8 subtype antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-CAN-CA-724-Ab03, GMP-CAN-CA-724-Ab04
Product Name Anti-Canine CA-724 human monoclonal antibody (mAb)
Target/Biomarker Canine Cancer Antigen 72-4 (AIV-A N8 subtype)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Canine Cancer Antigen 72-4 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N8 subtype antibodies in AIV-A N8 subtype level test of animal Dog/Canine with carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium.
Tag hFc
Products description Anti-Canine CA-724 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N8 subtype antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    CA-724, scientifically known as canine cancer antigen 724, is a biomarker of great importance in veterinary medicine, specifically in the realm of canine oncology. This biomarker is a glycoprotein, a protein molecule with carbohydrate chains attached, and it can be found in the bloodstream of dogs. What makes CA-724 particularly noteworthy is its association with various forms of cancer that affect dogs. In essence, CA-724 is a molecular signal that serves as a red flag for potential malignancies in dogs. It has been extensively studied and identified as a valuable indicator for diseases such as lymphoma, osteosarcoma, and mammary gland tumors in canine patients. When the levels of CA-724 are elevated in a dog's blood serum, it signals the possibility of cancer development or progression. Understanding CA-724's significance in canine health is critical for timely intervention and treatment. By detecting elevated CA-724 levels, veterinarians can identify the presence of cancer at an early stage, often before clinical symptoms manifest. This early detection is crucial as it allows for the prompt initiation of appropriate therapeutic measures, which can significantly improve the prognosis and quality of life for affected dogs.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment